2010—2021年度国家自然科学基金检验医学领域项目申请与资助情况分析  

Analysis and perspective of the grants funded by National Natural Science Foundation of China in the field of laboratory medicine from 2010 to 2021

作　　者：何彦[1] 李林静[2] 窦豆[3] He Yan;Li Linjing;Dou Dou(Department of Laboratory Medicine,Zhujiang Hospital of Southern Medical University,Guangzhou 510282,China;Center of Laboratory Medicine,the Second Hospital of Lanzhou University,Lanzhou 730030,China;Department of Health Science,National Natural Science Foundation of China,Beijing 100085,China)

机构地区：[1]南方医科大学珠江医院检验医学部,广州510282 [2]兰州大学第二医院检验医学中心,兰州730030 [3]国家自然科学基金委员会医学科学部,北京100085

出　　处：《中华检验医学杂志》2022年第7期693-703,共11页Chinese Journal of Laboratory Medicine

摘　　要：目的分析国家自然科学基金委员会(简称自然科学基金委)2010—2021年检验医学领域项目整体申请与资助情况。方法采集2010—2021年自然科学基金委检验医学领域申请与资助数据,重点针对学科内资助项目经费、地域、依托单位分布情况、关键词以及代表性论文进行分类统计,并分析和总结10余年来整体的项目特点。结果2010—2021年自然科学基金委检验医学领域共收到项目申请7746项、累计资助1152项、资助金额共计50631.7万元。项目申请数由2010年的228项增加至2021年1184项,项目资助数由2010的36项增加至2021年的137项,项目资助金额也相应地由2010年的1012.0万元增长至2021年的6538.0万元,均逐年上升。在检验医学领域(H26)中,分支学科H2605(分子生物学检验)与H2606(检验医学研究新技术与新方法)是受资助数量最多的2个方向,占59.7%(688/1152)。地域获资助情况中,北京、广东、上海、重庆、浙江和江苏为获资助数较多的前6个地区,占60.2%(695/1152)。30家依托单位获得检验医学领域826项资助,占总数71.7%(826/1152)。在检验领域1152资助项目中,肿瘤(37.1%,427项)、感染类疾病(26.9%,310项)、循环系统疾病(5.3%,61项)、自身免疫疾病(4.3%,49项)、内分泌与代谢性疾病(2.8%,32项)是出现频率较高的疾病类型;蛋白(33.4%,385项)、DNA(19.4%,224项)、RNA(17.3%,199项)、外泌体(6.0%,69项)和细胞(5.9%,68项)是研究较多的标志物;纳米技术(6.0%,69项)、质谱技术(3.0%,34项)、探针技术(1.82%,21项)、电化学技术(1.6%,19项)和二代测序技术(1.6%,18项)是研究较多的检验技术。检验领域10年来在建立参考值范围、鉴定新型疾病标志物、开发检验新技术等方面取得多项突破,形成多个具有特色方向的研究团队。结论自然科学基金委2010—2021年检验医学资助项目数及金额均显著上升,不同二级代码、地域和依托单位资助情况差异明显,研究Objective To analyze and summarize the overall results of application and funded projects by the National Natural Science Foundation of China(NSFC)in the field of laboratory medicine from 2010 to 2021.Methods Application and granting data in the field of laboratory medicine during 2010 and 2021 were collected from NSFC.Amount of funded projects,geographical distribution,supporting institution,distribution of keywords and representative research results in the field of laboratory medicine were analyzed.The overall characteristics of funded project in the past decades were summarized.Results From 2010 to 2021,NSFC received a total of 7746 project applications,among which 1152 projects and a total of 506.317 million RMB were funded in the field of laboratory medicine.Project applications increased from 228 in 2010 to 1184 in 2021.Among them,the number of funded projects increased from 36 in 2010 to 137 in 2021,accompanied by an increase in the amount of project grants from 10.12 million RMB in 2010 to 65.38 million RMB in 2021,but there is still a gap compared with other disciplines.In the field of laboratory medicine(H26),the sub-disciplines H2605(molecular biological examination)and H2606(new technologies and methods for laboratory medicine research)were the two directions with the highest number of funded grants,with a total of 688 grants,accounting for 59.7%(688/1152)of the total funded grants.Among the region of funding,Beijing,Guangdong,Shanghai,Chongqing,Zhejiang and Jiangsu were the top six regions with the successful funding,accounting for 60.2%(695/1152)funded projects.Thirty supporting institutions received 826 grants in the field of laboratory medicine,accounting for 71.7%(826/1152)funded projects.Among all the funded projects tumors(37.1%,427/1152),infectious diseases(26.9%,310/1152),circulatory diseases(5.3%,61/1152),autoimmune diseases(4.3%,49/1152),and endocrine and metabolic diseases(2.8%,32/1152)ranked the top disease types of successful funding;proteins(33.4%,385/1152),DNA(19.4%,224/1152),RNA(17.3

关 键 词：国家自然科学基金 检验医学 资助情况 

分 类 号：R-1[医药卫生]